Suffering from Symptoms of Parkinson's Disease?
Explore the HORIZON Research Study
As part of the HORIZON research study,
neurologists nationwide are evaluating an investigational Parkinson's disease
therapy (levodopa/carbidopa intestinal gel) delivered from an investigational study pump
system. This sytem infuses continuous delivery of the study drug during typical
To pre-qualify, participants must:
Study participants will receive all study related-
care, study medication, and the study pump system at no cost. Reimbursement for travel may also be provided.
be at least 30 years of age
have been diagnosed with Advanced PD
respond to levodopa
experience fluctuations in motor function ("on" and "off" times), AND
experience "off" times at least three hours a day
If you or someone you know qualifies for this study, you/he/she will be asked to
complete approximately 15 study visits over the course of approximately 16
To see if you or someone you know qualifies, click
the button below to complete the questionnaire on our website.
Care partners are welcome to answer the study questionnaire on a patient's
behalf to determine eligibility for participation.
To take the study questionnaire, please click here.